COMP <GO>
HAYW vs TMO // PIOTROSKI F-SCORE QUALITY
Hayward Holdings Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: HAYW 10
— TMO 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: HAYW
LAST: $16.12 (+3.53%) • MKT CAP: $3.24B
piotroski-score
9/9
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HAYW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HAYW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.00% | 41.00% | +7.00 | HAYW | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.60% | 9.30% | +0.30 | HAYW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.9x | 30.4x | -16.50 | HAYW | /valuation <GO> |
| Free Cash Flow Yield | 7.01% | 2.40% | +4.61 | HAYW | /fcf-yield <GO> |
| Operating Margin | 20.80% | 17.40% | +3.40 | HAYW | /operating-margins <GO> |
| Net Profit Margin | 13.50% | 15.10% | -1.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | 3.90% | +2.80 | HAYW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.47 | 4.50 | -2.03 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 8/9 | +1.00 | HAYW | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 84.5 | 59.1 | +25.30 | HAYW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.94 | +0.01 | HAYW | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.9x | 36.3x | -16.40 | HAYW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.24B | $262.22B | -$258.97B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HAYW REV | TMO REV | HAYW GROSS % | TMO GROSS % | HAYW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.12B | $44.56B | 48.0% | 44.0% | $227.3M | $6.29B |
| FY 2024 | $1.05B | $42.88B | 46.3% | 44.0% | $189.7M | $7.27B |
| FY 2023 | $992.5M | $42.86B | 44.0% | 44.0% | $139.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HAYW // BETA 0.95
TMO // BETA 0.94